What We Know and Don't Know.

Do We Know What We Do not Know? A Response to Celine Bonnet

Diagnostic and therapeutic challenges for dermatologists: What shall we do when we don’t know what to do?

What shall we do when we have done everything we could for the diagnosis and treatment of a patient, but were not successful? What shall we do when there is no definite treatment for a patient? What shall we do when we have no diagnosis or treatment for a patient? Some useful suggestions are presented here to get rid of these situations.

Anti-Vascular Endothelial Growth Factor Therapy in Pregnancy: What We Know, What We Don't Know, and What We Don't Know We Don't Know.

Travel Diarrhea in Childhood “First Part; what do we know?”

Virtual Teams: What We Know, What We Don't Know

This chapter reviews the extant empirical literature on virtual teams and presents what we know and what we don't know about them. Drawing upon the literature from both Organization Behavior and IS, we propose a framework that integrates the most important variables affecting virtual teams. The framework is then used to assess the effects of virtual teamwork on group processes and outcomes. The...

Molecular approaches to diagnosis of invasive aspergillosis what we know and what we do not know.

Invasive aspergillosis (IA) are a major complication in immunocompromized patients where can be serious and rapidly fatal. Early diagnosis and early appropriate antifungal treatment is important in reducing mortality and morbidity. But despite many efforts to develop detection methods, the diagnosis of IA still remains challenging and current conventional methods are limited for adequate diagno...